The pathophysiology, diagnosis, and treatment of constipation;Obstipation - Pathophysiologie, diagnose und therapie

Deutsches Arzteblatt

Volumn 106, Issue 25, 2009, Pages 424-432

  Müller Lissner, Stefan ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Constipation; Defecation; Dietary fiber; Laxatives

Indexed keywords

17 METHYLNALTREXONE; ANTHRAQUINONE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISACODYL; CISAPRIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GUANYLATE CYCLASE INHIBITOR; LACTULOSE; LAXATIVE; LINACLOTIDE; LUBIPROSTONE; MACROGOL; MAGNESIUM SULFATE; NALOXONE; OXYCODONE; PICOSULFATE SODIUM; PROKINETIC AGENT; PRUCALOPRIDE; TEGASEROD; UNCLASSIFIED DRUG;

CONSTIPATION; DEFECATION; DIAGNOSTIC PROCEDURE; DRUG MECHANISM; ENDOCRINE DISEASE; FECES; HUMAN; INTESTINE TRANSIT TIME; LIFESTYLE; MEDICAL LITERATURE; NUTRITION; NUTRITIONAL ASSESSMENT; PATHOPHYSIOLOGY; PATIENT EDUCATION; PELVIC ORGAN PROLAPSE; REVIEW; SENNA; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW;

CONSTIPATION; HUMANS;

EID: 70149099371     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2009.0424     Document Type: Review

References (25)

1. Everhart JE, Go VLW, Johannes RS, Fitzsimmons SC, Roth HP, White LR: A longitudinal survey of self-reported bowel habits in the United States. Dig Dis Sci 1989; 34: 1153-1162
2. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC: Functional Bowel Disorders. Gastroenterology 2006; 130: 1480-1491
3. Müller-Lissner SA, Kamm MA, Scarpignato C,Wald A: Myths and misconceptions about chronic constipation. Amer J Gastroenterol 2005; 100: 232-242
4. Müller-Lissner SA: The effect of wheat bran on stool weight and gastrointestinal transit time. A meta-analysis. Br med J 1988; 296: 615-617 (Pubitemid 18059446)
5. Voderholzer WA, Schatke W, Mühldorfer BE, Klauser AG, Birkner B, Müller-Lissner SA: Clinical response to dietary fiber treatment in chronic constipation. Am J Gastroenterol 1997, 92: 95-98. (Pubitemid 27027036)
6. Meissner W, Leyendecker P, Müller-Lissner S, et al.: A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation. Eur J Pain. 2009; 13: 56-64.
7. Thomas J, Karver S, Cooney GA, et al.: Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med 2008; 358: 2332-2343 (Pubitemid 351749157)
8. Bharoucha AE; Wald A, Enck P, Rao S: Functional Anorectal Disorders. Gastroenterology 2006; 130: 1510-1518
9. Francis CY, Whorwell P: Bran and irritable bowel syndrome: time for reappraisal. Lancet 1994; 344: 39-40. (Pubitemid 24199426)
10. Goei R: Anorectal function in patients with defecation disorders and asymptomatic subjects: evaluation with defecography. Radiology 1990; 174: 121-123
11. Dennison C, Prasad M, Lloyd A, Bhattacharyya SK, Dhawan R, Coyne K: The health-related quality of life and economic burden of constipation. Pharmacoeconomics 2005; 23: 461-476 (Pubitemid 40994135)
12. Cummings JH, Southgate DAT, Branch W, Houston H, Jenkins DJA, James WPT: Colonic response to dietary fibre from carrot, cabbage, apple, bran, and guar gum. Lancet 1978; 1: 5-8.
13. Müller-Lissner SA: What has happened to the cathartic colon? Gut 1996; 39: 486-488
14. Kinnunen O, Salokannel J: Constipation in the elderly long-stay patients: its treatment by magnesium hydroxide and bulk laxative. Ann Clin Res 1987; 19: 321-323 (Pubitemid 18051852)
15. Attar A, Lémann M, Ferguson A et al.: Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut 1999; 44: 226-230 (Pubitemid 29119366)
16. Passmore AP, Wilson-Davies K, Stoker C, Scott ME: Chronic constipation in long-stay elderly patients: a comparison of lactulose and a senna-fibre combination. BMJ 1993; 307: 769-771 (Pubitemid 23279322)
17. Kienzle-Horn S, Vix JM, Schuijt C, Peil H, Jordan CC, Kamm MA: Comparison of bisacodyl and sodium picosulfate in the treatment of chronic constipation. Curr Med Res Opinion 2007; 23: 891-899
18. Bengtsson M, Ohlsson B: Retrospective study of long-term treatment with sodium picosulfate. Eur J Gastroenterol Hepatol 2004; 16: 433-434 (Pubitemid 38453427)
19. Sonnenberg A, Müller AD: Constipation and cathartics as risk factors of colorectal cancer: a meta-analysis. Pharmacology 1993; 47(Suppl 1): 224-233 (Pubitemid 23291036)
20. Tack J, Müller-Lissner S: Treatment of chronic constipation: current pharmacologic approaches and future directions. Clin Gastroenterol Hepatol 2009; 7: 502-508
21. Johanson JF, Morton D, Geenen J, Ueno R: Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation. Am J Gastroenterol 2008; 103: 170-177
22. Andresen V, Camilleri M, Busciglio IA et al.: Effect of 5 days linaclotide on transit and bowel function in females with constipation- predominant irritable bowel syndrome. Gastroenterology 2007; 133: 761-768 (Pubitemid 47374145)
23. Chiarioni G, Whitehead WE, Pezza V, Morelli A, Bassotti G: Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia. Gastroenterology 2006; 130: 657-664 (Pubitemid 43374515)
24. Emmanuel AV, Kamm MA: Response to a behavioural treatment, biofeedback, in constipated patients is associated with improved gut transit and autonomic innervation. Gut. 2001; 49: 214-219
25. Mason HJ, Serrano-Ikkos E, Kamm MA: Psychologic morbidity in women with chronic idiopathic constipation. Am J Gastroenterol 2000; 95: 2852-2857